Tryten Technologies Inc.
USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F16M (Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports).
The verdict
According to USPTO PatentsView, Tryten ranks #38,044 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.
- #38,044
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (16.8/100)
- 2.9
- avg claims per patent
- -83%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R38044 · US Corporation #38,044 · 7 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- LOWER-Q #38,044/49,997
- PHOTO-FINISH True North Therapeut…
- CPC-NARROW F16M · 5 areas
- INNOV-LOW 16.8/100
- CLAIMS-SPARSE 2.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -83% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: True North Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Tryten’s 16.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Tryten
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Tryten · this assignee 17
Tryten · this assignee
17 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Tryten's Innovation Score is 16.8/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Tryten?
Each dot is one of Tryten’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tryten’s own 2.9 claims/patent is at or below the 10.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Tryten's grants concentrate
Tryten Technologies Inc. is a focused PatentsView assignee: 5 CPC subclasses with 14.3% of grants classified under F16M (Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2018. By volume, Tryten sits between True North Therapeutics, Inc. and Tuper S/A.
Who files at Tryten's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- True North Therap…
True North Therapeutics, Inc.
7 patents
- Trueing Studio
Trueing Studio LLC
7 patents
- Trussardi S p A
Trussardi S.p.A.
7 patents
- Truva
Truva Corporation
7 patents
- Tsurumi Manufactu…
Tsurumi Manufacturing Co., Ltd.
7 patents
- Tubel
Tubel LLC
7 patents
- Tulex Pharmaceuti…
Tulex Pharmaceuticals Inc.
7 patents
- Tuper S/A
Tuper S/A
7 patents
- Tryten ◀
Tryten Technologies Inc.
7 patents
What this shows Tryten holds 7 patents at rank #38,026, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Tryten
By rank, the assignees closest to #38,026 in granted patent volume.
- True North Therapeutics, Inc. #38,022 · 7 patents
- Trueing Studio LLC #38,023 · 7 patents
- Trussardi S.p.A. #38,024 · 7 patents
- Truva Corporation #38,025 · 7 patents
- Tsurumi Manufacturing Co., Ltd. #38,027 · 7 patents
- Tubel LLC #38,028 · 7 patents
- Tulex Pharmaceuticals Inc. #38,029 · 7 patents
- Tuper S/A #38,030 · 7 patents
Leaders in F16M (Frames)
Other assignees with the most granted patents in Tryten's primary technology class.
Tryten's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
17 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 28.6% |
| 2018 | 1 | 14.3% |
| 2019 | 3 | 42.9% |
| 2020 | 1 | 14.3% |
Which technologies does Tryten Technologies Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Tryten Technologies Inc.'s patent record in context - here's where to go next.
- Tryten Technologies Inc.'s lead technology class is F16M (Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports), 14.3% of its portfolio - see every assignee active in that class. Explore F16M
- Ranked #38,044 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Tryten Technologies Inc. against True North Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 16.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.